AniCura AB, headquartered in Sweden, is a leading provider of veterinary care across Europe, with a strong presence in several major operational regions. Founded in 2011, AniCura has rapidly established itself in the veterinary industry, focusing on high-quality medical services for companion animals. The company offers a comprehensive range of services, including advanced diagnostics, surgery, and preventive care, all delivered by a team of dedicated professionals. AniCura's commitment to innovation and excellence sets it apart, ensuring that pets receive the best possible care. With a growing network of clinics and hospitals, AniCura has achieved significant milestones, positioning itself as a trusted name in veterinary medicine. Its focus on animal welfare and client satisfaction has garnered recognition, making AniCura a prominent player in the European veterinary landscape.
How does AniCura AB's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Financial Intermediation industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
AniCura AB's score of 75 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
AniCura AB, headquartered in Sweden (SE), currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Mars, Incorporated, and therefore, its climate commitments and reduction initiatives are influenced by the parent company's sustainability strategies. AniCura AB inherits its climate targets and initiatives from Mars, Incorporated, which has established various industry-standard commitments. These include participation in the Science Based Targets initiative (SBTi), the Carbon Disclosure Project (CDP), and the RE100 initiative, all at a cascade level of 2. However, specific reduction targets or achievements for AniCura AB are not detailed in the available data. While no absolute emissions numbers are provided, AniCura AB's alignment with Mars, Incorporated's sustainability efforts indicates a commitment to reducing carbon emissions and addressing climate change within the veterinary care sector. The company is expected to follow the broader corporate family’s climate strategies, which aim to enhance environmental performance and sustainability.
Access structured emissions data, company-specific emission factors, and source documents
| 2012 | 2015 | 2021 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Scope 1 | 800 | 000,000,000 | 000,000,000 | 000,000,000 | - | 
| Scope 2 | 1,100 | 000,000,000 | 000,000,000 | 000,000,000 | - | 
| Scope 3 | 12,200 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | - | 
AniCura AB's Scope 3 emissions, which increased by 7% last year and increased significantly since 2012, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 76% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
AniCura AB has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.